Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Optimizing Pharmacologic Treatment for Neonatal Opioid Withdrawal Syndrome (OPTimize NOW): A Symptom-Based Dosing Approach

ClinicalTrials.gov ID: NCT05980260

Public ClinicalTrials.gov record NCT05980260. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 31, 2026, 12:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This clinical trial will help us learn more about how to best care for babies with Neonatal Opioid Withdrawal Syndrome, also called NOWS. Babies with NOWS often have tremors, a hard time sleeping, excessive crying, and trouble feeding. Some babies that have NOWS need medicine. Doctors have two ways of providing medicine that are widely used today: 1. Scheduled opioid taper approach. The baby gets medicine at regular times. As symptoms get better, the amount of medicine the baby gets decreases until the baby no longer needs medicine. This is called a medicine taper. 2. Symptom-based approach. The baby will only get medicine when they show signs of NOWS, instead of at regular times. If the baby is showing no signs of NOWS, no medicine will be given. We are doing the OPTimize NOW study to figure out the best way to give medicine to babies with NOWS.

Study identification

NCT ID
NCT05980260
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
HELP for NOWS Consortium
Network
Enrollment
626 participants

Conditions and interventions

Eligibility (public fields only)

Age range
1 Hour to 48 Hours
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 25, 2024 (Actual)
Primary completion
May 27, 2025 (Actual)
Completion
Jul 15, 2025 (Actual)
Last update posted
Oct 29, 2026

2024 – 2025

United States locations

U.S. sites
23
U.S. states
15
U.S. cities
19
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294 —
University of Arkansas for Medical Sciences Little Rock Arkansas 72205 —
ChristianaCare Wilmington Delaware 19801 —
University of South Florida Health Tampa Florida 33606 —
Sidney & Lois Eskenazi Hospital Indianapolis Indiana 46202 —
University of Louisville Hospital Jeffersonville Indiana 47130 —
University of Kansas Hospital Kansas City Kansas 66160 —
St. Elizabeth Healthcare Edgewood Kentucky 41017 —
Kentucky Children's Hospital Lexington Kentucky 40536 —
Norton Children's Hospital Louisville Kentucky 40202 —
Norton Women's and Children's Hospital Louisville Kentucky 40207 —
University of Nebraska Medical Center Omaha Nebraska 68198 —
AtlantiCare Regional Medical Center Atlantic City New Jersey 08401 —
University of New Mexico Health Sciences Center Albuquerque New Mexico 87131 —
University of Rochester Medical Center Rochester New York 14642 —
Good Samaritan Hospital Cincinnati Ohio 45202 —
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229 —
Kettering Health Main Campus Kettering Ohio 45429 —
Oklahoma Children's Hospital OU Health Oklahoma City Oklahoma 73104 —
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 —
Pennsylvania Hospital Philadelphia Pennsylvania 19107 —
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107 —
University of Utah Health Salt Lake City Utah 84158 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05980260, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 29, 2026 · Synced Oct 31, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05980260 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →